The risks of thrombotic and bleeding events in patients receiving PEGylated asparaginase for treatment of acute lymphoblastic leukemia.

被引：0
|
作者：
Mautner, Ben
Pierce, Eric
Mort, Joseph
DiBenedetto, Samantha
Wells, Leah
Ghamsari, Farid
Morse, Emily
Morris, Amy
Keng, Michael Kenneth
El Chaer, Firas
机构：
[1] Univ Virginia Hlth Syst, Charlottesville, VA USA
[2] Univ Virginia, Charlottesville, VA USA
[3] Univ Virginia Sch Med, Charlottesville, VA USA
[4] UVA Hlth Syst, Charlottesville, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19015
引用
收藏
页码：E19015 / E19015
页数：1
相关论文
共 50 条
  • [1] Thrombotic events in adults with acute lymphoblastic leukemia.
    Cserti, CM
    Brandwein, J
    Lipton, JH
    McLeod, AG
    Messner, H
    Minden, MD
    Schimmer, AD
    Schuh, AC
    Seki, JT
    Yeo, EL
    Yi, QL
    Wells, RA
    [J]. BLOOD, 2004, 104 (11) : 747A - 747A
  • [2] HIGH INCIDENCE OF HYPERAMMONEMIA IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING PEGYLATED ASPARAGINASE
    Heitink-Polle, K. M. J.
    Prinsen, B. H. C. M. T.
    de Koning, T. J.
    Bierings, M. B.
    van Hasselt, P. M.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S89 - S89
  • [3] Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia
    Avramis, Vassilios I.
    Tiwari, Prakash Nidhi
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (03): : 241 - 254
  • [4] Venous thrombotic events in Philadelphia chromosome-like acute lymphoblastic leukemia.
    Patel, Anand Ashwin
    Sellers, Meredith
    Zhang, Yanming
    Dinner, Shira Naomi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Sustained and Prolonged Asparagine Depletion by Multiple Doses of Intravenous Pegylated Asparaginase in the Treatment of Adults with Newly Diagnosed Acute Lymphoblastic Leukemia.
    Douer, Dan
    Watkins, Kristy
    Mark, Lisa
    Ann, Mohrbacher
    Yang, Allen S.
    Avramis, Vassilios I.
    [J]. BLOOD, 2008, 112 (11) : 673 - 673
  • [6] Oral Manifestations in Pediatric Patients Receiving Chemotherapy for Acute Lymphoblastic Leukemia.
    Ponce-Torres, Elena
    del Socorro Ruiz-Rodriguez, Ma.
    Alejo-Gonzalez, Francisco
    Hernandez-Sierra, Juan Francisco
    Pozos-Guillen, Amaury de J.
    [J]. JOURNAL OF CLINICAL PEDIATRIC DENTISTRY, 2010, 34 (03) : 275 - 279
  • [7] L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
    Egler, Rachel A.
    Ahuja, Sanjay P.
    Matloub, Yousif
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2016, 7 (02) : 62 - 71
  • [8] An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events
    Farrell, Katrina
    Fyfe, Andrew
    Allan, Jonathan
    Tait, R. Campbell
    Leach, Mike
    [J]. LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2568 - 2574
  • [9] Asparaginase use for the treatment of acute lymphoblastic leukemia
    Barba, Pere
    Luis Dapena, Jose
    Montesinos, Pau
    Rives, Susana
    [J]. MEDICINA CLINICA, 2017, 148 (05): : 225 - 231
  • [10] Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase
    Perusini, Maria Agustina
    Andrews, Claire
    Atenafu, Eshetu G.
    Gupta, Vikas
    Maze, Dawn
    Schuh, Andre C.
    Yee, Karen W. L.
    Bankar, Aniket
    Davidson, Marta B.
    Richard-Carpentier, Guillaume
    Chan, Steven M.
    Sibai, Jad
    Schimmer, Aaron D.
    Minden, Mark D.
    Sibai, Hassan
    [J]. HEMATOLOGY, 2024, 29 (01)
12345